Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Potential new drugs for treating PCOS were identified.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

A new method to make Finasteride is more cost-effective and yields 16%.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Certain Dibenzo derivatives may help treat prostate cancer.

Piedraia hortae fungi dissolve both the outer and inner layers of hair.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

New compounds were made that are promising for prostate cancer therapy.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

1,2,3,4-tetrahydroquinoline compounds are great for stable, pure blue hair dye.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Some dibenzo compounds might help treat cancer with fewer side effects.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

The research helps understand how finasteride works and aids drug development.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New progesterone-based compounds can block male hormones.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.